FIELD: medicine.
SUBSTANCE: method involves determining protein molecules like γ-interferon in blood serum. One month after treatment, γ-interferon content is determined by applying immunoenzyme assay. The content being less than 35 pg/ml, the treatment is judged effective. The content being greater than 35 pg/ml, the treatment is judged ineffective, and drug dose is to be adjusted or another drug is to be prescribed.
EFFECT: high specificity and sensitivity of the method.
2 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DIFFERENTIAL DIAGNOSTICS OF DIFFERENT AUTOIMMUNE THYROID LESIONS | 2006 |
|
RU2315322C1 |
METHOD OF TREATING HASHIMOTO DISEASE | 2009 |
|
RU2410089C1 |
METHOD OF TAKING PREVENTIVE MEASURES AIMED AT TREATMENT OF THYROID GLAND DISEASES IN CHILDREN OF EARLY AGE BORN FROM MOTHERS WITH OPPORTUNISTIC INFECTIONS | 2007 |
|
RU2355447C1 |
METHOD FOR PREDICTION OF CLINICAL COURSE OF AUTOIMMUNE THYROIDITIS | 2011 |
|
RU2456612C1 |
METHOD FOR TREATING AUTOIMMUNE THYROIDITIS WITH CYCLOFERON | 2006 |
|
RU2306932C1 |
METHOD TO TREAT PATIENTS SUFFERING AUTOIMMUNE THYROIDITIS | 2000 |
|
RU2180587C1 |
METHOD FOR TREATING CHILDREN FOR AUTOIMMUNE THYROIDITIS | 2002 |
|
RU2221535C1 |
METHOD OF AFTERTREATMENT OF CHILDREN AND TEENAGERS WITH AUTOIMMUNE THYROIDITIS IN COMBINATION WITH CHRONIC PHARYNGOTONSILLITIS | 2006 |
|
RU2332978C2 |
METHOD OF TREATING HYPOTHYROIDISM WITH DALARGIN | 2023 |
|
RU2814749C1 |
METHOD FOR SELECTING PREGNANT WOMEN DURING I-II TRIMESTERS FOR CARRYING OUT THE CORRECTING THERAPY OF THYROID DYSFUNCTION | 2005 |
|
RU2297794C1 |
Authors
Dates
2008-04-27—Published
2006-07-19—Filed